JAMES G. STEVENSON, PHARM.D.; TIMOTHY R. COVINGTON, PHARM.D.
To the editor: A number of inquiries have been made to the West Virginia University Drug Information Center requesting information on the value of edetate disodium (EDTA) in chelation therapy of atherosclerosis, angina pectoris, and related disorders. The American Academy of Medical Preventics (AAMP) has been distributing information on this subject to the public. We would like to alert physicians and other health professionals to the misleading claims made by this group and clarify the status of EDTA chelation therapy.
The AAMP has suggested that patients with atherosclerotic disease complete a "computer-analyzed" medical history questionnaire, have a "trace mineral analysis"
Learn more about subscription options.
Register Now for a free account.
STEVENSON JG, COVINGTON TR. Chelation Therapy in Atherosclerosis. Ann Intern Med. 1982;97:789–790. doi: 10.7326/0003-4819-97-5-789_2
Download citation file:
Published: Ann Intern Med. 1982;97(5):789-790.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only